Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Big Rock Partners
BRPA

Buy BRPA Stock

BRPA
See BRPA stock price and Buy/Sell Big Rock Partners with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
BRPA

Big Rock Partners (BRPA)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Big Rock Partners (BRPA)

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Market Cap
$48.59M
1 Year High
$18.30
Volume
1 Year Low
$0.49
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch BRPA stock

BRPA Stock News

BRPA stock rating

What analysts recommend for BRPA stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

BRPA price target

What analysts think BRPA will be worth
Low $0
High $18.30
Current $0
Target $2

BRPA earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.07
-0.14
-0.21
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.08
Actual EPS
Q3 2022

Buy BRPA Stock

BRPA
See BRPA stock price and Buy/Sell Big Rock Partners with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch BRPA stock
  • gritter330 avatar
  • smaxi avatar
  • patelsandy1981 avatar
  • RightWayLes avatar
  • ositog21 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.